Testing Effects of Behavioral Coaching and Virtual Exercise on Aging in Blood Cancer Survivors Aged 50 and Older

What this Trial Is About

Older survivors of blood cancer face a high risk of faster biological aging, which raises their chances of developing multiple age-related health problems. This trial is a Phase 2 randomized control study designed to test behavioral and exercise interventions aimed at slowing aging in people aged 50 and older who have survived blood cancer. The study addresses important gaps such as the necessary exercise dose and duration for this group. Participants are assigned to one of two groups. One group receives virtually supervised moderate-intensity aerobic exercise combined with behavioral coaching to help maintain exercise adherence. The other group has access to a virtual exercise platform offering exercise classes and educational sessions but does not receive behavioral coaching. The interventions are delivered remotely using a virtual exercise platform. During the study, participants adherence to the exercise program is measured at 6 and 12 months after enrollment. Physical function is also assessed using a 6-minute walk test at 6 months. Researchers will monitor participants throughout the study to evaluate how well they stick to the exercise routines and the impact on physical abilities. The study is expected to last until March 2033, allowing for long-term assessment of these interventions.

Halt Aging in Survivors of Blood Cancers